Renew Pharmaceuticals is committed to delivering cutting edge healthcare solutions, particularly in the area of connected health.
New anti-counterfeiting regulations were introduced by several countries & regions where Renew Pharmaceuticals product was sold requiring the track & trace of prescription medicines through the entire supply chain. Under the directive, all new packs of prescription medicines placed on the market had to bear two safety features: a verifiable unique identifier (serialised code) and an anti-tamper device.
In order to continue trading into key markets and to comply with regulations, Renew Pharmaceuticals needed to serialise and aggregate their products accordingly. They found a perfect partner in CXV Global, whose market knowledge, bespoke serialisation solution and local engineering service network supported their continued market supply.